Literature DB >> 11946058

A new DNA intercalating drug: Methoxy-9-ellipticine.

B Festy1, J Poisson, C Paoletti.   

Abstract

Entities:  

Year:  1971        PMID： 11946058     DOI： 10.1016/0014-5793(71)80176-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  4 in total

1.  A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

Authors:  J B Le Pecq; C Gosse; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

2.  Changes in superhelical density of closed circular deoxyribonucleic acid by intercalation of anti-R-plasmid drugs and primaquine.

Authors:  R G Allison; F E Hahn
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

3.  Biotransformation of ellipticine into 5-formyl ellipticine by Choisya ternata strains.

Authors:  K Kouadio; M Rideau; C Ganser; J C Chénieux; C Viel
Journal:  Plant Cell Rep       Date:  1984-10       Impact factor: 4.570

4.  Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.

Authors:  J Bernadou; B Meunier; G Meunier; C Auclair; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.